Ventricular Tachycardia Cohort

The goal of this observational study is to detect the long-term risk of a composite endpoint event in adult patients with ventricular tachycardia (VT) who are managed with catheter ablation or non-ablation management (including modern drug therapy and/or ICD therapy).

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Ventricular Tachycardia (VT) Arrhythmias, Cardiac Cardiac Conduction System Disease Cardiovascular Diseases Heart Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Tachycardia Tachycardia, Ventricular

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Sustained ventricular tachycardia (VT), defined as VT lasting ≥30 seconds or requiring intervention due to hemodynamic compromise within 30 seconds; or Clinically significant non-sustained VT (NSVT) where the treating clinician has determined that therapeutic intervention is necessary.

Exclusion criteria

Concurrent participation in any interventional clinical trial that, in the judgment of the investigator, could interfere with the data collection or outcome assessment of this observational study.

Treatment and study plan

Intervention

Device

Treatment with intervention of catheter ablation or Implantable cardioverter defibrillator.

Primary outcomes

Composite of death and recurrence of ventricular tachycardia

Time frame: 1 year

Sponsors and collaborators

Lead sponsor

Beijing Anzhen Hospital

Other

Registry information

Important dates

Study start: 2025
Primary completion: 2029
Study completion: 2029
First posted: Sep 2, 2025
Registry last updated: Sep 2, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not Yet Recruiting